Calton & Associates’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-2,151
| Closed | -$370K | – | 417 |
|
2021
Q3 | $370K | Sell |
2,151
-17
| -0.8% | -$2.92K | 0.08% | 249 |
|
2021
Q2 | $272K | Sell |
2,168
-71
| -3% | -$8.91K | 0.05% | 312 |
|
2021
Q1 | $304K | Buy |
2,239
+189
| +9% | +$25.7K | 0.06% | 283 |
|
2020
Q4 | $262K | Sell |
2,050
-81
| -4% | -$10.4K | 0.05% | 291 |
|
2020
Q3 | $240K | Buy |
+2,131
| New | +$240K | 0.05% | 280 |
|